Pediatric and Ambulatory Research in Infectious Diseases
PARI
Real Time Surveillance of Pediatric Infectious Diseases in French Ambulatory Care: PARI Study
1 other identifier
observational
400,000
1 country
1
Brief Summary
Many ambulatory networks are mainly based on diagnoses made by first-line physicians not specifically trained to join the network. Here we aim to set up a surveillance network on pediatric infectious diseases with an investment in teaching with specific trainings of participating pediatricians, increasing in use of point of care tests, and automated data extraction from the computers of the pediatricians.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2017
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 26, 2017
CompletedFirst Submitted
Initial submission to the registry
July 8, 2020
CompletedFirst Posted
Study publicly available on registry
July 15, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 27, 2030
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 2, 2030
February 8, 2024
January 1, 2024
13 years
July 8, 2020
February 7, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Evaluation of the number of infectious diseases
proportion of children under 16 years, with infectious disease
5 years
Secondary Outcomes (2)
Evaluation of the use of point of care tests
5 years
Evaluation of the antibiotic treatments
5 years
Eligibility Criteria
Children under 16 years with infectious disease
You may qualify if:
- Children under 16 years of age with at least one infectious disease among:
- pharyngitis
- otitis
- pneumonia
- influenza
- bronchiolitisz
- varicella
- gastroenteritis
- enterovirus disease
- bordetella pertussis disease
- using the same same software, Axi5-Infansoft (developed by CompuGroup Medical, Nanterre, France)
You may not qualify if:
- parental refusal
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Association Clinique Thérapeutique Infantile du val de Marnelead
- AFPA (Association Française de Pédiatrie Ambulatoire)collaborator
- GlaxoSmithKlinecollaborator
- Sanoficollaborator
- Pfizercollaborator
- Merck Sharp & Dohme LLCcollaborator
Study Sites (1)
AFPA
Créteil, France
Related Publications (1)
Cohen R, Bechet S, Gelbert N, Frandji B, Vie Le Sage F, Thiebault G, Kochert F, Cahn-Sellem F, Werner A, Ouldali N, Levy C. New Approach to the Surveillance of Pediatric Infectious Diseases From Ambulatory Pediatricians in the Digital Era. Pediatr Infect Dis J. 2021 Jul 1;40(7):674-680. doi: 10.1097/INF.0000000000003116.
PMID: 33657594DERIVED
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Robert Cohen
Association Clinique et Thérapeutique Infantile du Val de Marne
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 5 Years
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 8, 2020
First Posted
July 15, 2020
Study Start
June 26, 2017
Primary Completion (Estimated)
June 27, 2030
Study Completion (Estimated)
August 2, 2030
Last Updated
February 8, 2024
Record last verified: 2024-01